Grants offered to identify mitochondrial biomarkers

News

Author: Parkinson's Life editorsPublished: 24 August 2017

Prep: Cook: Serves:

The Michael J Fox Foundation is offering one- to two-year grants for any Parkinson’s research that will develop or improve tools to identify mitochondrial biomarkers for the disease.

The goal of the initiative is to assist in the discovery of mitochondrial biomarkers to assess Parkinson’s diagnosis, patient stratification and disease progression. Any knowledge gained from the study will be applied to human biospecimens – biological material obtained for the purpose of research.

The deadline for submission of pre-proposals is 27 September 2017. Funding will be allocated in May 2018.

Last Month

Next Month

Go Back

Share this story

Comments

Interviews

Parkinson’s hacks: why the simplest solutions can be the most life-changing

We interview Mileha, the designer who invents life-changing products

World Poetry Day: Parkinson’s, marriage and grief

We speak to the winner of our Parkinson’s poetry competition 2019

Dancing with Parkinson’s: “I feel completely changed”

We talk to Parkinson’s campaigner Massimiliano Iachini

35 new Parkinson’s drug trials launched in last year

Researchers launched 35 new clinical trials of Parkinson’s drug therapies in the last year, according to recent findings published in the ‘Journal of Parkinson’s Disease’. The 2023 Parkinson’s drug development pipeline report noted a slight decrease in active trials compared to the 2022 update (down from 147 to 139 overall). About one-third of trials were still in Phase 1, half were in Phase 2 – and just 20 (14%) were in Phase 3, raising concerns about ‘slow progress’. However, of the active trials logged on ClinicalTrials.gov at the time of the latest report, 35 were found to be newly registered. The report authors concluded: “The slow progress and lack of agents transitioning from Phase 2 to Phase 3 is concerning, but collective efforts by various stakeholders are being made to accelerate the clinical trial process, with the aim of bringing new therapies to the [Parkinson’s] community sooner.”

Parkinson’s Europe co-founder Lizzie Graham wins World Parkinson Coalition award

Parkinson’s Europe co-founder Lizzie Graham has won a World Parkinson Coalition (WPC) award for her contribution to the Parkinson’s community. Lizzie is one of four people set to receive the Robin Elliott Award – which is given out every three years to individuals whose efforts best embody the goals and ethos of the WPC. She will be presented with the award in a ceremony at the World Parkinson’s Congress, which will be held in Barcelona later this year. Commenting on the news of Lizzie’s award, Parkinson’s Europe President, Veronica Clark, said: “Lizzie is Lizzie, and we love her for who she is and what she has done for us all – for people with Parkinson’s past and present and, I’m sure, future.” Lizzie co-founded the European Parkinson’s Disease Association (renamed Parkinson’s Europe last year) in 1992. She has since held several roles within the organisation – including secretary general and…

Study explores predictors of cognitive impairment in Parkinson’s disease

Cognitive impairment can affect some people with Parkinson’s – and may greatly impact their quality of life. Now, researchers in China have examined the possible risk factors for cognitive impairment in those with the condition. The study analysed data from 409 people with Parkinson’s within two years of their involvement in the Parkinson’s Progression Markers Initiative (PPMI) – an international study that follows people with and without the condition over time. The participants, who were newly diagnosed and experiencing normal cognitive function at the start of the research, were studied for at least five years. Published in ‘Frontiers in Aging Neuroscience’, the results indicate that older age at onset, high blood pressure and worse baseline motor symptoms may be among factors that could contribute to an increased risk of developing cognitive impairment. The researchers cautioned that “a larger sample and much more comprehensive assessment, and prolonged follow-up, will be required”.

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
CAPTCHA
*
- By proceeding you agree to our
Name
This field is for validation purposes and should be left unchanged.

Grants offered to identify mitochondrial biomarkers

News

Author: Parkinson's Life editorsPublished: 24 August 2017

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Interviews

Parkinson’s hacks: why the simplest solutions can be the most life-changing

Carers' Corner

World Poetry Day: Parkinson’s, marriage and grief

Interviews

Dancing with Parkinson’s: “I feel completely changed”

35 new Parkinson’s drug trials launched in last year

Parkinson’s Europe co-founder Lizzie Graham wins World Parkinson Coalition award

Study explores predictors of cognitive impairment in Parkinson’s disease

{title}

Subscribe

Grants offered to identify mitochondrial biomarkers

News

Author: Parkinson's Life editorsPublished: 24 August 2017

Last Month

Next Month

Share this story

Comments

Related articles

Interviews

Parkinson’s hacks: why the simplest solutions can be the most life-changing

Carers' Corner

World Poetry Day: Parkinson’s, marriage and grief

Interviews

Dancing with Parkinson’s: “I feel completely changed”

35 new Parkinson’s drug trials launched in last year

Parkinson’s Europe co-founder Lizzie Graham wins World Parkinson Coalition award

Study explores predictors of cognitive impairment in Parkinson’s disease

{title}

Subscribe

Sign in